FIELD: medicine, narcology. SUBSTANCE: method involves determination of activity of the following enzymes in blood serum of patient: gamma-glutamyltransferase, alkaline phosphatase, alpha-hydroxybutyrate dehydrogenase and high density lipoprotein cholesterol content. Alcoholism is diagnosed at the following indices: at simultaneous increase of activity of gamma-glutamyltransferase and alkaline phosphatase (above 1.25-fold) and activity of alpha-hydroxybutyrate dehydrogenase and content of high density lipoprotein cholesterol (above 1.15-fold) as compared with normal values, i. e. above 50 U/l, 175 U/l and 1.4 mM. EFFECT: improved method of diagnosis. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR STAGE THREE ALCOHOLISM | 2010 |
|
RU2450269C2 |
| AGENT FOR ALCOHOLIC ABSINENT SYNDROME ARRESTING | 2000 |
|
RU2167655C1 |
| METHOD FOR PREDICTING TREATMENT EFFECTIVENESS IN PATIENTS SUFFERING FROM DEPRESSIVE DISORDERS CAUSED BY SELECTIVE SEROTONINERGIC ANTIDEPRESSANTS | 2000 |
|
RU2177253C1 |
| METHOD FOR DIAGNOSING THE CASES OF CHRONIC CARDIAC ISCHEMIA DISEASE | 2001 |
|
RU2200951C2 |
| METHOD FOR REVEALING CLINICAL SPECIFIC OF BOUNDARY NEUROPSYCHIC DISORDERS | 2000 |
|
RU2168312C1 |
| METHOD FOR PREDICTING THE FLOW OF DEPRESSIVE REACTIONS | 2003 |
|
RU2239190C1 |
| METHOD FOR ALLEVIATING COMPLICATED ABSTINENCE SYNDROME | 1992 |
|
RU2067442C1 |
| METHOD FOR PREDICTING CLINICAL BEHAVIOR OF CARDIAC ISCHEMIA DISEASE | 2001 |
|
RU2228534C2 |
| METHOD FOR TREATING THE CASES OF SCHIZOPHRENIA | 2000 |
|
RU2164799C1 |
| METHOD FOR PREDICTING NEGATIVE CLINICAL MANIFESTATIONS IN SCHIZOPHRENIA FLOW | 2001 |
|
RU2188577C1 |
